KR20140006775A - 세포 특성화 - Google Patents

세포 특성화 Download PDF

Info

Publication number
KR20140006775A
KR20140006775A KR1020137007313A KR20137007313A KR20140006775A KR 20140006775 A KR20140006775 A KR 20140006775A KR 1020137007313 A KR1020137007313 A KR 1020137007313A KR 20137007313 A KR20137007313 A KR 20137007313A KR 20140006775 A KR20140006775 A KR 20140006775A
Authority
KR
South Korea
Prior art keywords
cell
cells
coding rna
profile
rna profile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020137007313A
Other languages
English (en)
Korean (ko)
Inventor
빈센트 오브리언
크리스 힐리어
Original Assignee
시스테믹 스코틀랜드 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 시스테믹 스코틀랜드 리미티드 filed Critical 시스테믹 스코틀랜드 리미티드
Publication of KR20140006775A publication Critical patent/KR20140006775A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809Methods for determination or identification of nucleic acids involving differential detection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/178Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
KR1020137007313A 2010-08-23 2011-08-19 세포 특성화 Ceased KR20140006775A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1014049.9 2010-08-23
GBGB1014049.9A GB201014049D0 (en) 2010-08-23 2010-08-23 Cell characterisation
PCT/GB2011/001241 WO2012025709A1 (en) 2010-08-23 2011-08-19 Cell characterisation

Publications (1)

Publication Number Publication Date
KR20140006775A true KR20140006775A (ko) 2014-01-16

Family

ID=42984495

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020137007313A Ceased KR20140006775A (ko) 2010-08-23 2011-08-19 세포 특성화

Country Status (12)

Country Link
US (4) US20130196875A1 (enExample)
EP (1) EP2609217B1 (enExample)
JP (1) JP2013535979A (enExample)
KR (1) KR20140006775A (enExample)
CN (1) CN103403180A (enExample)
AU (1) AU2011294936A1 (enExample)
BR (1) BR112013004202A2 (enExample)
CA (1) CA2847151C (enExample)
GB (1) GB201014049D0 (enExample)
IL (1) IL224888B (enExample)
SG (2) SG10201506595QA (enExample)
WO (1) WO2012025709A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2859119A2 (en) * 2012-06-12 2015-04-15 Institute for Systems Biology Complex rna composition of bodily fluids
WO2017160880A1 (en) * 2016-03-14 2017-09-21 Aelan Cell Technologies, Inc. Compositions and methods for the quality control of stem cell preparations
SG11201809902QA (en) 2016-05-09 2018-12-28 Sistemic Scotland Ltd Functional prediction of cellular functions by means of microrna expression profiling in mesenchymal stem cells
JP6629770B2 (ja) * 2017-01-19 2020-01-15 シスメックス株式会社 細胞の分化状態を評価する方法
JP6918062B2 (ja) * 2017-01-19 2021-08-11 シスメックス株式会社 細胞の分化状態を評価する方法
GB2570404A (en) * 2018-01-22 2019-07-24 Sistemic Scotland Ltd Cell contamination assay
WO2020072545A1 (en) * 2018-10-01 2020-04-09 Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center MicroRNA TRANSCRIPTIONAL SIGNATURE (miR-TS) EVALUATION OF STEM CELLS
CN113658636B (zh) * 2021-07-22 2025-08-05 未来智人再生医学研究院(广州)有限公司 一种评估多能干细胞质量的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050123952A1 (en) * 2003-09-04 2005-06-09 Griffey Richard H. Methods of rapid detection and identification of bioagents using microRNA
JP5697297B2 (ja) * 2004-05-14 2015-04-08 ロゼッタ ジノミクス リミテッド マイクロnasおよびその使用
EP1966390A1 (en) * 2005-12-29 2008-09-10 Exiqon A/S Detection of tissue origin of cancer
CN101316935B (zh) * 2006-11-28 2012-02-29 博奥生物有限公司 一种用于诊断食道癌的芯片
CN101622350A (zh) * 2006-12-08 2010-01-06 奥斯瑞根公司 作为干预治疗靶标的miR-126调控基因和通路
WO2008112283A2 (en) * 2007-03-12 2008-09-18 Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Microrna profiling of androgen responsiveness for predicting the appropriate prostate cancer treatment
WO2009036332A1 (en) * 2007-09-14 2009-03-19 Asuragen, Inc. Micrornas differentially expressed in cervical cancer and uses thereof
WO2009062503A1 (en) * 2007-11-14 2009-05-22 Dandrit Biotech A/S Micro rnas as markers of the functional state of a dendritic cell
CA2717030A1 (en) * 2008-02-28 2009-09-03 The Ohio State University Research Foundation Microrna signatures associated with cytogenetics and prognosis in acute myeloid leukemia (aml) and uses thereof
US20100003674A1 (en) * 2008-07-03 2010-01-07 Cope Frederick O Adult stem cells, molecular signatures, and applications in the evaluation, diagnosis, and therapy of mammalian conditions
WO2010082039A1 (en) * 2009-01-19 2010-07-22 Sistemic Scotland Limited Methods employing non-coding rna expression assays

Also Published As

Publication number Publication date
SG190837A1 (en) 2013-07-31
BR112013004202A2 (pt) 2019-09-24
IL224888B (en) 2020-10-29
SG10201506595QA (en) 2015-10-29
CA2847151C (en) 2023-11-28
US20200080148A1 (en) 2020-03-12
EP2609217A1 (en) 2013-07-03
JP2013535979A (ja) 2013-09-19
EP2609217B1 (en) 2019-03-27
US20130196875A1 (en) 2013-08-01
CA2847151A1 (en) 2012-03-01
GB201014049D0 (en) 2010-10-06
WO2012025709A1 (en) 2012-03-01
CN103403180A (zh) 2013-11-20
US20230183803A1 (en) 2023-06-15
US20170218446A1 (en) 2017-08-03
AU2011294936A1 (en) 2013-04-11

Similar Documents

Publication Publication Date Title
Pollen et al. Low-coverage single-cell mRNA sequencing reveals cellular heterogeneity and activated signaling pathways in developing cerebral cortex
Liu et al. Purification and characterization of human neural stem and progenitor cells
US20230183803A1 (en) Cell characterisation
Messmer et al. Transcriptional heterogeneity in naive and primed human pluripotent stem cells at single-cell resolution
Wilson et al. Dynamic microRNA expression programs during cardiac differentiation of human embryonic stem cells: role for miR-499
US10626445B2 (en) Early developmental genomic assay for characterizing pluripotent stem cell utility and safety
Parchem et al. Two miRNA clusters reveal alternative paths in late-stage reprogramming
Szafranska et al. Accurate molecular characterization of formalin-fixed, paraffin-embedded tissues by microRNA expression profiling
Ortmann et al. Naive pluripotent stem cells exhibit phenotypic variability that is driven by genetic variation
US20220356461A1 (en) High-throughput single-cell libraries and methods of making and of using
Fang et al. miRNA expression profile of colon cancer stem cells compared to non-stem cells using the SW1116 cell line
Stelzer et al. Global analysis of parental imprinting in human parthenogenetic induced pluripotent stem cells
Martinez Analysis of gene expression and gene silencing in human macrophages
Chakraborty et al. Single‐cell sequencing of miRNAs: A modified technology
Juzenas et al. inDrops-2: a flexible, versatile and cost-efficient droplet microfluidic approach for high-throughput scRNA-seq of fresh and preserved clinical samples
Git et al. PMC42, a breast progenitor cancer cell line, has normal-like mRNA and microRNA transcriptomes
Albert et al. MiRNome and transcriptome aided pathway analysis in human regulatory T cells
Sampath et al. Identifying translationally regulated genes during stem cell differentiation
Bonetta An expression of interest
Teske et al. Targeted CRISPR-Cas9 screening identifies transcription factor network controlling murine haemato-endothelial fate commitment
Brodská Single-cell RNA sequencing in leukemia
Strand Transcriptomic identification of cell types in the lower urinary tract
Hu et al. Measuring microRNA expression in mouse hematopoietic stem cells
Wu et al. Oocytes, a single cell and a tissue
Ciani Regulatory modules discovery and mesenchymal stem cells characterization from high-throughput cancer genomics data

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20130322

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20160819

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20170714

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20180129

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20170714

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I